UA75560C2 - New interferon receptor 1-binding proteins, dna, coding them and methods for modulation of cells reaction to interferons - Google Patents

New interferon receptor 1-binding proteins, dna, coding them and methods for modulation of cells reaction to interferons Download PDF

Info

Publication number: UA75560C2
Authority: UA; Ukraine
Prior art keywords: dna molecule; sequence; recombinant dna; mentioned; protein
Prior art date: 1997-01-15

Application number

UA99084631A

Other languages

English (en)

Ukrainian (uk)

Original Assignee

Yeda Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-15

Filing date

1998-01-15

Publication date

2006-05-15

1998-01-15 Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev

2006-05-15 Publication of UA75560C2 publication Critical patent/UA75560C2/uk

Links

102000014150 Interferons Human genes 0.000 title claims abstract description 25
108010050904 Interferons Proteins 0.000 title claims abstract description 25
238000000034 method Methods 0.000 title claims abstract description 25
102000014914 Carrier Proteins Human genes 0.000 title claims description 15
108091008324 binding proteins Proteins 0.000 title claims description 15
238000006243 chemical reaction Methods 0.000 title abstract description 10
229940047124 interferons Drugs 0.000 title abstract description 10
102000001617 Interferon Receptors Human genes 0.000 title description 3
108010054267 Interferon Receptors Proteins 0.000 title description 3
108090000623 proteins and genes Proteins 0.000 claims abstract description 102
102000004169 proteins and genes Human genes 0.000 claims abstract description 93
108020004511 Recombinant DNA Proteins 0.000 claims abstract description 34
230000014509 gene expression Effects 0.000 claims abstract description 26
108020004414 DNA Proteins 0.000 claims abstract description 22
230000027455 binding Effects 0.000 claims abstract description 15
229940079322 interferon Drugs 0.000 claims abstract description 15
206010028980 Neoplasm Diseases 0.000 claims abstract description 12
238000002560 therapeutic procedure Methods 0.000 claims abstract description 7
201000011510 cancer Diseases 0.000 claims abstract description 5
230000002708 enhancing effect Effects 0.000 claims abstract 2
210000004027 cell Anatomy 0.000 claims description 79
102000053602 DNA Human genes 0.000 claims description 34
230000000692 anti-sense effect Effects 0.000 claims description 34
108020004999 messenger RNA Proteins 0.000 claims description 27
239000012634 fragment Substances 0.000 claims description 26
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 23
239000002773 nucleotide Substances 0.000 claims description 23
125000003729 nucleotide group Chemical group 0.000 claims description 23
108020005544 Antisense RNA Proteins 0.000 claims description 12
239000003184 complementary RNA Substances 0.000 claims description 12
230000000295 complement effect Effects 0.000 claims description 11
210000005260 human cell Anatomy 0.000 claims description 11
230000004044 response Effects 0.000 claims description 11
239000000427 antigen Substances 0.000 claims description 10
108091007433 antigens Proteins 0.000 claims description 10
102000036639 antigens Human genes 0.000 claims description 10
210000000056 organ Anatomy 0.000 claims description 8
239000013604 expression vector Substances 0.000 claims description 7
238000002054 transplantation Methods 0.000 claims description 6
239000008194 pharmaceutical composition Substances 0.000 claims description 5
239000000945 filler Substances 0.000 claims description 2
125000003275 alpha amino acid group Chemical group 0.000 claims 2
238000012258 culturing Methods 0.000 claims 2
230000001939 inductive effect Effects 0.000 claims 2
241000555745 Sciuridae Species 0.000 claims 1
102000033673 type I interferon receptor binding proteins Human genes 0.000 claims 1
108091009654 type I interferon receptor binding proteins Proteins 0.000 claims 1
230000036647 reaction Effects 0.000 abstract 1
239000002299 complementary DNA Substances 0.000 description 42
150000001413 amino acids Chemical class 0.000 description 30
230000000694 effects Effects 0.000 description 29
108020003175 receptors Proteins 0.000 description 25
102000005962 receptors Human genes 0.000 description 25
241000282414 Homo sapiens Species 0.000 description 21
239000013612 plasmid Substances 0.000 description 19
240000004808 Saccharomyces cerevisiae Species 0.000 description 18
239000011324 bead Substances 0.000 description 18
108090000765 processed proteins & peptides Proteins 0.000 description 18
210000001519 tissue Anatomy 0.000 description 15
239000013598 vector Substances 0.000 description 15
108091034117 Oligonucleotide Proteins 0.000 description 14
102000004190 Enzymes Human genes 0.000 description 12
108090000790 Enzymes Proteins 0.000 description 12
229940088598 enzyme Drugs 0.000 description 12
208000027697 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency Diseases 0.000 description 11
238000013519 translation Methods 0.000 description 11
230000012010 growth Effects 0.000 description 10
108010042955 Calcineurin Proteins 0.000 description 9
102000004631 Calcineurin Human genes 0.000 description 9
108010068032 caltractin Proteins 0.000 description 9
230000036755 cellular response Effects 0.000 description 9
239000000284 extract Substances 0.000 description 9
108010045403 Calcium-Binding Proteins Proteins 0.000 description 8
102000005701 Calcium-Binding Proteins Human genes 0.000 description 8
206010035226 Plasma cell myeloma Diseases 0.000 description 8
102000003708 Protein arginine N-methyltransferase Human genes 0.000 description 8
108020000912 Protein arginine N-methyltransferase Proteins 0.000 description 8
108020001507 fusion proteins Proteins 0.000 description 8
102000037865 fusion proteins Human genes 0.000 description 8
201000000050 myeloid neoplasm Diseases 0.000 description 8
229920001184 polypeptide Polymers 0.000 description 8
102000004196 processed proteins & peptides Human genes 0.000 description 8
238000010396 two-hybrid screening Methods 0.000 description 8
108010033040 Histones Proteins 0.000 description 7
230000003993 interaction Effects 0.000 description 7
238000004519 manufacturing process Methods 0.000 description 7
150000007523 nucleic acids Chemical group 0.000 description 7
241000283725 Bos Species 0.000 description 6
241001465754 Metazoa Species 0.000 description 6
230000004913 activation Effects 0.000 description 6
238000004458 analytical method Methods 0.000 description 6
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
238000003780 insertion Methods 0.000 description 6
230000037431 insertion Effects 0.000 description 6
239000000203 mixture Substances 0.000 description 6
102000039446 nucleic acids Human genes 0.000 description 6
108020004707 nucleic acids Proteins 0.000 description 6
IJJWOSAXNHWBPR-HUBLWGQQSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-(6-hydrazinyl-6-oxohexyl)pentanamide Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCCCC(=O)NN)SC[C@@H]21 IJJWOSAXNHWBPR-HUBLWGQQSA-N 0.000 description 5
244000068988 Glycine max Species 0.000 description 5
235000010469 Glycine max Nutrition 0.000 description 5
102000003839 Human Proteins Human genes 0.000 description 5
108090000144 Human Proteins Proteins 0.000 description 5
241000701044 Human gammaherpesvirus 4 Species 0.000 description 5
108091081021 Sense strand Proteins 0.000 description 5
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
108091081024 Start codon Proteins 0.000 description 5
102000040945 Transcription factor Human genes 0.000 description 5
108091023040 Transcription factor Proteins 0.000 description 5
230000009471 action Effects 0.000 description 5
239000000074 antisense oligonucleotide Substances 0.000 description 5
238000012230 antisense oligonucleotides Methods 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
230000009036 growth inhibition Effects 0.000 description 5
230000011987 methylation Effects 0.000 description 5
238000007069 methylation reaction Methods 0.000 description 5
235000015097 nutrients Nutrition 0.000 description 5
230000001105 regulatory effect Effects 0.000 description 5
239000000758 substrate Substances 0.000 description 5
230000004083 survival effect Effects 0.000 description 5
102100026189 Beta-galactosidase Human genes 0.000 description 4
108091026890 Coding region Proteins 0.000 description 4
102000006947 Histones Human genes 0.000 description 4
102000016397 Methyltransferase Human genes 0.000 description 4
108060004795 Methyltransferase Proteins 0.000 description 4
108091028043 Nucleic acid sequence Proteins 0.000 description 4
210000001744 T-lymphocyte Anatomy 0.000 description 4
108010005774 beta-Galactosidase Proteins 0.000 description 4
239000003153 chemical reaction reagent Substances 0.000 description 4
238000010835 comparative analysis Methods 0.000 description 4
235000013305 food Nutrition 0.000 description 4
230000002068 genetic effect Effects 0.000 description 4
238000009396 hybridization Methods 0.000 description 4
239000006166 lysate Substances 0.000 description 4
230000037361 pathway Effects 0.000 description 4
210000001995 reticulocyte Anatomy 0.000 description 4
230000011664 signaling Effects 0.000 description 4
238000013518 transcription Methods 0.000 description 4
230000035897 transcription Effects 0.000 description 4
238000012546 transfer Methods 0.000 description 4
241000701161 unidentified adenovirus Species 0.000 description 4
210000005253 yeast cell Anatomy 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
229920000936 Agarose Polymers 0.000 description 3
208000003174 Brain Neoplasms Diseases 0.000 description 3
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
108010024636 Glutathione Proteins 0.000 description 3
108060003951 Immunoglobulin Proteins 0.000 description 3
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
241001529936 Murinae Species 0.000 description 3
108700026244 Open Reading Frames Proteins 0.000 description 3
101710146873 Receptor-binding protein Proteins 0.000 description 3
108700008625 Reporter Genes Proteins 0.000 description 3
239000000872 buffer Substances 0.000 description 3
229910001424 calcium ion Inorganic materials 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
210000000805 cytoplasm Anatomy 0.000 description 3
239000003599 detergent Substances 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
229960003180 glutathione Drugs 0.000 description 3
102000018358 immunoglobulin Human genes 0.000 description 3
238000001114 immunoprecipitation Methods 0.000 description 3
230000005764 inhibitory process Effects 0.000 description 3
230000003211 malignant effect Effects 0.000 description 3
239000012528 membrane Substances 0.000 description 3
229930182817 methionine Natural products 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
210000004940 nucleus Anatomy 0.000 description 3
230000001124 posttranscriptional effect Effects 0.000 description 3
238000012545 processing Methods 0.000 description 3
230000009467 reduction Effects 0.000 description 3
238000012163 sequencing technique Methods 0.000 description 3
238000012360 testing method Methods 0.000 description 3
102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
108020000948 Antisense Oligonucleotides Proteins 0.000 description 2
206010006187 Breast cancer Diseases 0.000 description 2
208000026310 Breast neoplasm Diseases 0.000 description 2
101800001415 Bri23 peptide Proteins 0.000 description 2
101800000655 C-terminal peptide Proteins 0.000 description 2
102400000107 C-terminal peptide Human genes 0.000 description 2
102000052510 DNA-Binding Proteins Human genes 0.000 description 2
108700020911 DNA-Binding Proteins Proteins 0.000 description 2
230000004568 DNA-binding Effects 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
102000055027 Protein Methyltransferases Human genes 0.000 description 2
108700040121 Protein Methyltransferases Proteins 0.000 description 2
102000044126 RNA-Binding Proteins Human genes 0.000 description 2
108700020471 RNA-Binding Proteins Proteins 0.000 description 2
102000004389 Ribonucleoproteins Human genes 0.000 description 2
108010081734 Ribonucleoproteins Proteins 0.000 description 2
101000902133 Schizosaccharomyces pombe (strain 972 / ATCC 24843) Histone-lysine N-methyltransferase, H3 lysine-9 specific Proteins 0.000 description 2
RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
244000042038 Tropaeolum tuberosum Species 0.000 description 2
241000700605 Viruses Species 0.000 description 2
230000006978 adaptation Effects 0.000 description 2
125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 2
210000004556 brain Anatomy 0.000 description 2
239000011575 calcium Substances 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
210000004292 cytoskeleton Anatomy 0.000 description 2
230000002950 deficient Effects 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
230000006870 function Effects 0.000 description 2
239000000499 gel Substances 0.000 description 2
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
230000003053 immunization Effects 0.000 description 2
230000005847 immunogenicity Effects 0.000 description 2
238000011534 incubation Methods 0.000 description 2
230000006698 induction Effects 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
238000002372 labelling Methods 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
229940046166 oligodeoxynucleotide Drugs 0.000 description 2
230000008520 organization Effects 0.000 description 2
239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
241000894007 species Species 0.000 description 2
238000010186 staining Methods 0.000 description 2
230000002194 synthesizing effect Effects 0.000 description 2
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
230000001052 transient effect Effects 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
241001430294 unidentified retrovirus Species 0.000 description 2
OYYYNGYSZOOWKO-MEOQXRMASA-N (2s)-2-amino-3-[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-4-methylsulfanylbutanoic acid Chemical compound O[C@@H]1[C@H](O)[C@@H](CC(CSC)[C@H](N)C(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 OYYYNGYSZOOWKO-MEOQXRMASA-N 0.000 description 1
QDUDQAJMMWFNEO-UHFFFAOYSA-N 2-(sulfoamino)propane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(CC(O)=O)(NS(O)(=O)=O)C(O)=O QDUDQAJMMWFNEO-UHFFFAOYSA-N 0.000 description 1
MDMVIFMPYCNJMB-UHFFFAOYSA-N 2-[[6-[bis(carboxymethyl)amino]-2,5-dioxohexyl]-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(=O)CCC(=O)CN(CC(O)=O)CC(O)=O MDMVIFMPYCNJMB-UHFFFAOYSA-N 0.000 description 1
101710091601 21 kDa protein Proteins 0.000 description 1
241000881711 Acipenser sturio Species 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical compound NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 1
108020004491 Antisense DNA Proteins 0.000 description 1
108010039627 Aprotinin Proteins 0.000 description 1
101000995861 Arabidopsis thaliana Regulatory protein NPR1 Proteins 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
238000003462 Bender reaction Methods 0.000 description 1
LZJRNLRASBVRRX-ZDUSSCGKSA-N Boldine Chemical compound CN1CCC2=CC(O)=C(OC)C3=C2[C@@H]1CC1=C3C=C(OC)C(O)=C1 LZJRNLRASBVRRX-ZDUSSCGKSA-N 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
239000002126 C01EB10 - Adenosine Substances 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
101710117451 Calmodulin-like protein Proteins 0.000 description 1
108010019670 Chimeric Antigen Receptors Proteins 0.000 description 1
241001078969 Clematis viorna Species 0.000 description 1
241000611750 Coregonus kiyi Species 0.000 description 1
102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 1
108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 1
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
108010036949 Cyclosporine Proteins 0.000 description 1
201000003883 Cystic fibrosis Diseases 0.000 description 1
241000701022 Cytomegalovirus Species 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
244000153389 Diospyros oleifera Species 0.000 description 1
235000002256 Diospyros oleifera Nutrition 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
108091005515 EGF module-containing mucin-like hormone receptors Proteins 0.000 description 1
102100030013 Endoribonuclease Human genes 0.000 description 1
101710199605 Endoribonuclease Proteins 0.000 description 1
241000283074 Equus asinus Species 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
102000018932 HSP70 Heat-Shock Proteins Human genes 0.000 description 1
108010027992 HSP70 Heat-Shock Proteins Proteins 0.000 description 1
208000009889 Herpes Simplex Diseases 0.000 description 1
241000282412 Homo Species 0.000 description 1
241000701024 Human betaherpesvirus 5 Species 0.000 description 1
102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 1
108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 1
102000002227 Interferon Type I Human genes 0.000 description 1
108010014726 Interferon Type I Proteins 0.000 description 1
102000007438 Interferon alpha-beta Receptor Human genes 0.000 description 1
108010086140 Interferon alpha-beta Receptor Proteins 0.000 description 1
102000003996 Interferon-beta Human genes 0.000 description 1
108090000467 Interferon-beta Proteins 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
102000043136 MAP kinase family Human genes 0.000 description 1
108091054455 MAP kinase family Proteins 0.000 description 1
102000043129 MHC class I family Human genes 0.000 description 1
108091054437 MHC class I family Proteins 0.000 description 1
102000029749 Microtubule Human genes 0.000 description 1
108091022875 Microtubule Proteins 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
102000019148 NF-kappaB-inducing kinase activity proteins Human genes 0.000 description 1
101150063042 NR0B1 gene Proteins 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
239000004365 Protease Substances 0.000 description 1
101800004937 Protein C Proteins 0.000 description 1
102000001253 Protein Kinase Human genes 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 1
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
241000220317 Rosa Species 0.000 description 1
101800001700 Saposin-D Proteins 0.000 description 1
102400000827 Saposin-D Human genes 0.000 description 1
206010039491 Sarcoma Diseases 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
101710113029 Serine/threonine-protein kinase Proteins 0.000 description 1
244000269722 Thea sinensis Species 0.000 description 1
102000006601 Thymidine Kinase Human genes 0.000 description 1
108020004440 Thymidine kinase Proteins 0.000 description 1
241000656145 Thyrsites atun Species 0.000 description 1
YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 1
229960005305 adenosine Drugs 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
230000000259 anti-tumor effect Effects 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
239000003816 antisense DNA Substances 0.000 description 1
229960004405 aprotinin Drugs 0.000 description 1
238000003556 assay Methods 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000008827 biological function Effects 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
244000309464 bull Species 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
244000309466 calf Species 0.000 description 1
230000007248 cellular mechanism Effects 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
210000003793 centrosome Anatomy 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
230000021572 chromosome movement towards spindle pole Effects 0.000 description 1
229960001265 ciclosporin Drugs 0.000 description 1
238000010367 cloning Methods 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
238000004737 colorimetric analysis Methods 0.000 description 1
238000004590 computer program Methods 0.000 description 1
238000010276 construction Methods 0.000 description 1
229930182912 cyclosporin Natural products 0.000 description 1
108010057085 cytokine receptors Proteins 0.000 description 1
102000003675 cytokine receptors Human genes 0.000 description 1
RGWHQCVHVJXOKC-SHYZEUOFSA-N dCTP Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-N 0.000 description 1
230000007850 degeneration Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
150000001982 diacylglycerols Chemical class 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
230000000459 effect on growth Effects 0.000 description 1
238000002079 electron magnetic resonance spectroscopy Methods 0.000 description 1
238000010828 elution Methods 0.000 description 1
230000006862 enzymatic digestion Effects 0.000 description 1
230000009088 enzymatic function Effects 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
235000012907 honey Nutrition 0.000 description 1
210000004251 human milk Anatomy 0.000 description 1
235000020256 human milk Nutrition 0.000 description 1
210000004408 hybridoma Anatomy 0.000 description 1
230000005965 immune activity Effects 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
230000028993 immune response Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
230000004957 immunoregulator effect Effects 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
229940124589 immunosuppressive drug Drugs 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
238000009434 installation Methods 0.000 description 1
230000010354 integration Effects 0.000 description 1
229960001388 interferon-beta Drugs 0.000 description 1
235000021109 kimchi Nutrition 0.000 description 1
108010052968 leupeptin Proteins 0.000 description 1
GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
239000002502 liposome Substances 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
238000005259 measurement Methods 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
230000010534 mechanism of action Effects 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
208000037819 metastatic cancer Diseases 0.000 description 1
208000011575 metastatic malignant neoplasm Diseases 0.000 description 1
206010061289 metastatic neoplasm Diseases 0.000 description 1
WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
244000005700 microbiome Species 0.000 description 1
210000004688 microtubule Anatomy 0.000 description 1
230000011278 mitosis Effects 0.000 description 1
238000003032 molecular docking Methods 0.000 description 1
230000009456 molecular mechanism Effects 0.000 description 1
230000000877 morphologic effect Effects 0.000 description 1
230000035772 mutation Effects 0.000 description 1
230000035407 negative regulation of cell proliferation Effects 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
229940055729 papain Drugs 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
229950000964 pepstatin Drugs 0.000 description 1
108010091212 pepstatin Proteins 0.000 description 1
FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
230000004983 pleiotropic effect Effects 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
210000004896 polypeptide structure Anatomy 0.000 description 1
238000004321 preservation Methods 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
229960000856 protein c Drugs 0.000 description 1
108060006633 protein kinase Proteins 0.000 description 1
238000001814 protein method Methods 0.000 description 1
230000009145 protein modification Effects 0.000 description 1
108020000494 protein-tyrosine phosphatase Proteins 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
230000006337 proteolytic cleavage Effects 0.000 description 1
238000000746 purification Methods 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000010076 replication Effects 0.000 description 1
230000001718 repressive effect Effects 0.000 description 1
210000002345 respiratory system Anatomy 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
238000012552 review Methods 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
239000000523 sample Substances 0.000 description 1
238000012216 screening Methods 0.000 description 1
238000011935 selective methylation Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
230000035939 shock Effects 0.000 description 1
108091006024 signal transducing proteins Proteins 0.000 description 1
102000034285 signal transducing proteins Human genes 0.000 description 1
230000007727 signaling mechanism Effects 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
238000004114 suspension culture Methods 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
230000009897 systematic effect Effects 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
210000001541 thymus gland Anatomy 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000026683 transduction Effects 0.000 description 1
238000001890 transfection Methods 0.000 description 1
230000005945 translocation Effects 0.000 description 1
108091008578 transmembrane receptors Proteins 0.000 description 1
102000027257 transmembrane receptors Human genes 0.000 description 1
229910052722 tritium Inorganic materials 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
230000004614 tumor growth Effects 0.000 description 1
230000029812 viral genome replication Effects 0.000 description 1
238000012800 visualization Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1007—Methyltransferases (general) (2.1.1.)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Biophysics (AREA)
Epidemiology (AREA)
Toxicology (AREA)
Transplantation (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

UA99084631A 1997-01-15 1998-01-15 New interferon receptor 1-binding proteins, dna, coding them and methods for modulation of cells reaction to interferons UA75560C2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3563697P	1997-01-15	1997-01-15
PCT/US1998/000671 WO1998031796A1 (en)	1997-01-15	1998-01-15	Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons

Publications (1)

Publication Number	Publication Date
UA75560C2 true UA75560C2 (en)	2006-05-15

Family

ID=21883894

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UA99084631A UA75560C2 (en)	1997-01-15	1998-01-15	New interferon receptor 1-binding proteins, dna, coding them and methods for modulation of cells reaction to interferons

Country Status (20)

Country	Link
US (1)	US7264945B2 (zh)
EP (1)	EP1019500B1 (zh)
JP (1)	JP4614473B2 (zh)
KR (2)	KR100591988B1 (zh)
CN (1)	CN1212398C (zh)
AT (1)	ATE342972T1 (zh)
AU (1)	AU731206C (zh)
BG (1)	BG64829B1 (zh)
BR (1)	BR9806755A (zh)
CA (1)	CA2276111A1 (zh)
CZ (1)	CZ299096B6 (zh)
DE (1)	DE69836226T2 (zh)
DK (1)	DK1019500T3 (zh)
EA (1)	EA003250B1 (zh)
EE (1)	EE04819B1 (zh)
ES (1)	ES2275297T3 (zh)
IL (2)	IL130960A0 (zh)
NO (1)	NO326104B1 (zh)
UA (1)	UA75560C2 (zh)
WO (1)	WO1998031796A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020119129A1 (en) *	1997-01-15	2002-08-29	Yeda Research And Development Co. Ltd.	Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons
WO2003055506A1 (fr) *	2001-12-27	2003-07-10	Takeda Chemical Industries, Ltd.	Medicaments pour la prevention et le traitement du cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4220759A1 (de) *	1992-06-24	1994-01-05	Inst Genbiologische Forschung	DNA-Sequenzen für Oligosaccharid-Transporter, Plasmide, Bakterien und Pflanzen enthaltend einen Transporter sowie Verfahren zur Herstellung und Transformation von Hefestämmen zur Identifikation des Transporteers
IL107378A (en) *	1993-10-24	2005-05-17	Yeda Res & Dev	SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE
US6242587B1 (en) *	1996-10-02	2001-06-05	The University Of North Carolina At Chapel Hill	DNA molecules encoding a calcium-integrin binding protein

1998
- 1998-01-15 EE EEP199900272A patent/EE04819B1/xx unknown
- 1998-01-15 CA CA002276111A patent/CA2276111A1/en not_active Abandoned
- 1998-01-15 KR KR1020057004384A patent/KR100591988B1/ko not_active IP Right Cessation
- 1998-01-15 BR BR9806755-9A patent/BR9806755A/pt not_active Application Discontinuation
- 1998-01-15 IL IL13096098A patent/IL130960A0/xx active IP Right Grant
- 1998-01-15 DK DK98901804T patent/DK1019500T3/da active
- 1998-01-15 EA EA199900663A patent/EA003250B1/ru not_active IP Right Cessation
- 1998-01-15 WO PCT/US1998/000671 patent/WO1998031796A1/en not_active Application Discontinuation
- 1998-01-15 AT AT98901804T patent/ATE342972T1/de active
- 1998-01-15 CZ CZ0247199A patent/CZ299096B6/cs not_active IP Right Cessation
- 1998-01-15 ES ES98901804T patent/ES2275297T3/es not_active Expired - Lifetime
- 1998-01-15 EP EP98901804A patent/EP1019500B1/en not_active Expired - Lifetime
- 1998-01-15 JP JP53237098A patent/JP4614473B2/ja not_active Expired - Fee Related
- 1998-01-15 CN CNB98801808XA patent/CN1212398C/zh not_active Expired - Fee Related
- 1998-01-15 KR KR1019997006407A patent/KR100799828B1/ko not_active IP Right Cessation
- 1998-01-15 AU AU58240/98A patent/AU731206C/en not_active Ceased
- 1998-01-15 DE DE69836226T patent/DE69836226T2/de not_active Expired - Lifetime
- 1998-01-15 UA UA99084631A patent/UA75560C2/uk unknown
1999
- 1999-07-09 NO NO19993412A patent/NO326104B1/no not_active IP Right Cessation
- 1999-07-14 IL IL130960A patent/IL130960A/en not_active IP Right Cessation
- 1999-08-02 BG BG103627A patent/BG64829B1/bg unknown
2002
- 2002-12-04 US US10/309,280 patent/US7264945B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EE04819B1 (et)	2007-04-16
AU731206C (en)	2002-05-16
WO1998031796A8 (en)	1999-05-20
EE9900272A (et)	2000-02-15
AU5824098A (en)	1998-08-07
EA199900663A1 (ru)	2000-02-28
DE69836226T2 (de)	2007-02-01
CN1243544A (zh)	2000-02-02
CN1212398C (zh)	2005-07-27
US7264945B2 (en)	2007-09-04
KR100799828B1 (ko)	2008-01-31
EP1019500B1 (en)	2006-10-18
IL130960A (en)	2008-03-20
WO1998031796A1 (en)	1998-07-23
BR9806755A (pt)	2000-03-14
NO326104B1 (no)	2008-09-22
EA003250B1 (ru)	2003-02-27
ES2275297T3 (es)	2007-06-01
JP4614473B2 (ja)	2011-01-19
CA2276111A1 (en)	1998-07-23
DK1019500T3 (da)	2007-02-19
BG64829B1 (bg)	2006-05-31
KR20050046779A (ko)	2005-05-18
ATE342972T1 (de)	2006-11-15
BG103627A (en)	2000-04-28
CZ247199A3 (cs)	2000-01-12
NO993412D0 (no)	1999-07-09
JP2001508306A (ja)	2001-06-26
AU731206B2 (en)	2001-03-29
EP1019500A4 (en)	2004-04-07
NO993412L (no)	1999-07-09
KR100591988B1 (ko)	2006-06-21
IL130960A0 (en)	2001-01-28
CZ299096B6 (cs)	2008-04-23
KR20000070181A (ko)	2000-11-25
DE69836226D1 (de)	2006-11-30
EP1019500A2 (en)	2000-07-19
US20030176678A1 (en)	2003-09-18

Publication	Publication Date	Title
Gure et al.	1997	SSX: a multigene family with several members transcribed in normal testis and human cancer
Bennett et al.	1999	Cloning and characterization of a close homologue of human UDP-N-acetyl-α-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6: evidence for genetic but not functional redundancy
Toki et al.	1997	Human small Maf proteins form heterodimers with CNC family transcription factors and recognize the NF-E2 motif
Yazawa et al.	1999	Lack of class II transactivator causes severe deficiency of HLA‐DR expression in small cell lung cancer
Chan et al.	1995	52-kD SS-A/Ro: genomic structure and identification of an alternatively spliced transcript encoding a novel leucine zipper-minus autoantigen expressed in fetal and adult heart.
Rimoldi et al.	1999	cDNA and protein characterization of human MAGE‐10
John et al.	1989	Surface expression of the T cell receptor complex requires charged residues within the α chain transmembrane region
Abe et al.	2000	Structure, expression, and chromosomal localization of the human gene encoding a germinal center-associated nuclear protein (GANP) that associates with MCM3 involved in the initiation of DNA replication
UA75560C2 (en)	2006-05-15	New interferon receptor 1-binding proteins, dna, coding them and methods for modulation of cells reaction to interferons
US20070148686A1 (en)	2007-06-28	Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof
Ruegg et al.	1996	B4B, a novel growth-arrest gene, is expressed by a subset of progenitor/pre-B lymphocytes negative for cytoplasmic mu-chain.
US7524928B2 (en)	2009-04-28	IFN receptor 1 binding proteins
Yu et al.	1997	Molecular cloning of a functional murine arginine-specific mono-ADP-ribosyltransferase and its expression in lymphoid cells
Prost et al.	2002	Characterization of a novel hematopoietic marker expressed from early embryonic hematopoietic stem cells to adult mature lineages
WO1999002677A1 (fr)	1999-01-21	Gene issu de chondrocyte humain
AU720324B2 (en)	2000-05-25	Growth arrest gene compositions and methods
Méténier‐Delisse et al.	1997	Isolation and molecular characterization of bovine Rhesus‐like transcripts and chromosome mapping of the relevant locus
Dahm et al.	2001	Transcripts of Fliz1, a nuclear zinc finger protein, are expressed in discrete foci of the murine fetal liver
Hayakawa et al.	2001	Genomic organization, tissue expression, and cellular localization of AF3p21, a fusion partner of MLL in therapy‐related leukemia
WO1996011212A1 (fr)	1996-04-18	Nouveau ligand de tyrosine kinase de type recepteur
EP1780277A1 (en)	2007-05-02	IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons
MXPA99006595A (en)	2000-01-21	Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons
Takahashi et al.	1984	I-2 DNA Replication
PT1019500E (pt)	2007-01-31	Proteinas de ligação ao novo receptor do ifn 1, dna que as codifica e metodos de modulação da resposta celular à interferões